Cargando…
Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion
We have studied differentially regulated nuclear proteome of the clinical tissue specimens of glioblastoma (GBM, WHO Grade IV) and lower grades of gliomas (Grade II and III) using high resolution mass spectrometry- based quantitative proteomics approach. The results showed altered expression of many...
Autores principales: | Gupta, Manoj Kumar, Polisetty, Ravindra Varma, Sharma, Rakesh, Ganesh, Raksha A., Gowda, Harsha, Purohit, Aniruddh K., Ankathi, Praveen, Prasad, Komal, Mariswamappa, Kiran, Lakshmikantha, Akhila, Uppin, Megha S., Sundaram, Challa, Gautam, Poonam, Sirdeshmukh, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662741/ https://www.ncbi.nlm.nih.gov/pubmed/31358880 http://dx.doi.org/10.1038/s41598-019-47360-9 |
Ejemplares similares
-
Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers
por: Polisetty, Ravindra Varma, et al.
Publicado: (2016) -
Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis
por: Gautam, Poonam, et al.
Publicado: (2012) -
Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation
por: Tripathi, Priyanka H., et al.
Publicado: (2022) -
Atypical craniocerebral eumycetoma: A case report and review of literature
por: Rao, Kommu Venkateswara, et al.
Publicado: (2015) -
Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)